Article
GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.
Carcinogenesis - 1 Feb 2011
Moore L E, Baris D R, Figueroa J D, Garcia-Closas M, Karagas M R, Schwenn M R, Johnson A T, Lubin J H, Hein D W, Dagnall C L, Colt J S, Kida M, Jones M A, Schned A R, Cherala S S, Chanock S J, Cantor K P, Silverman D T, Rothman N
Abstract excerpt
Associations between bladder cancer risk and NAT2 and GSTM1 polymorphisms have emerged as some of the most consistent findings in the genetic epidemiology of common metabolic polymorphisms and cancer, but their interaction with tobacco use, intensity and duration remain unclear. In a New England population-based case-control study of urothelial carcinoma, we collected mouthwash samples from 1088 of 1171 cases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.